Go Deep
PAVmed Inc.
PAVmed Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 24,109 | -0.2 | 0.52 | 0.88 | 217.43 |
| Oct 2026 | 24,070 | -0.2 | 0.55 | 0.88 | 230.28 |
| Oct 2026 | 24,075 | -0.2 | 0.55 | 0.88 | 228.26 |
| Oct 2026 | 24,121 | -0.2 | 0.51 | 0.88 | 213.34 |
| Oct 2026 | 24,127 | -0.2 | 0.51 | 0.88 | 211.44 |
| Oct 2026 | 24,166 | -0.1 | 0.48 | 0.88 | 198.15 |
| Oct 2026 | 24,179 | -0.1 | 0.47 | 0.88 | 193.50 |
PAVmed Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 33,000.0 | 22,000.0 | 52,000.0 | 5,000.0 |
| Net Profit | -5,384,000.0 | -60,000.0 | -1,263,000.0 | -5,383,000.0 |
| EPS | -0.9 | -4.4 | -2.4 | -8.7 |
PAVmed Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 71,000.0 | 2,995,000.0 | 2,452,000.0 | 377,000.0 | — |
| Net Profit | 401,000.0 | 39,791,000.0 | -64,175,000.0 | -88,983,000.0 | — |
| EPS | 1.8 | 97.1 | -274.8 | -450.9 | — |
PAVmed Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 38,812,000.0 | 30,660,000.0 | 33,119,000.0 | 53,980,000.0 | — |
| Total Liabilities | 16,512,000.0 | 37,693,000.0 | 57,137,000.0 | 43,046,000.0 | — |
| Total Equity | 33,967,000.0 | -2,495,000.0 | -53,831,000.0 | -9,681,000.0 | — |
Owes vs Owns
PAVmed Inc. owed $0.52 for every $1 it owned in Jun 2026, down from $0.80 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.52× | 0.43× | 1.23× | 1.73× | 0.80× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
PAVmed Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 4.0%Inventory 0.6%Fixed assets (tangible) 5.4%Long-term investments 87.9%Other assets 2.1%
How it's funded — Dec 2025
Short-term debt 28.6%Long-term debt 4.3%Payables 1.7%Other liabilities 7.9%Shareholders' equity 57.5%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1.5 | 1.2 | 19.6 | 39.7 |
| Receivables | 0.0 | 0.0 | 0.1 | 0.0 |
| Inventory | 0.2 | 0.3 | 0.5 | 0.3 |
| Fixed assets (tangible) | 2.1 | 2.7 | 6.0 | 5.5 |
| Intangible assets | 0.0 | 0.0 | 1.4 | 3.4 |
| Long-term investments | 34.1 | 25.6 | 0.0 | 0.0 |
| Other assets | 0.8 | 0.9 | 5.4 | 5.0 |
| Liabilities & equity | ||||
| Short-term debt | 11.1 | 29.1 | 44.2 | 33.6 |
| Long-term debt | 1.7 | 2.2 | 3.0 | 1.8 |
| Payables | 0.7 | 0.7 | 1.8 | 2.7 |
| Other liabilities | 3.1 | 5.7 | 8.2 | 4.8 |
| Shareholders' equity | 22.3 | -7.0 | -24.0 | 10.9 |
| Net tangible assets | 34.0 | -2.5 | -55.3 | -13.1 |
PAVmed Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -5,206,000.0 | -33,554,000.0 | -52,036,000.0 | -70,985,000.0 | — |
| Investing Activities | -31,000.0 | -16,184,000.0 | 758,000.0 | -4,740,000.0 | — |
| Financing Activities | 5,590,000.0 | 31,284,000.0 | 31,173,000.0 | 38,211,000.0 | — |